A strong tumor‐suppressive effect of activin A‐mDia2 inhibition was also seen when tumors formed by SCC13 Act cells were treated ex vivo with recombinant human FST and/or SMIFH2, an mDia2 inhibitor (Isogai et al, 2015b). Here, DIAPH3 is linked to neoplasm.